Results 181 to 190 of about 4,384,774 (216)

Hospital-Level Determinants of Mortality After Pancreas Surgery: A Global Infrastructure Analysis. [PDF]

Ann Surg
Hidalgo Salinas C, Tinguely P, Raptis DA, van Herwijnen S, Javed AA, Perera R, Ferrone CR, Wolfgang CL, Fusai GK, PancreasGroup.org Collaborative.   +9 more
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Association of HIV post-exposure prophylaxis knowledge and utilisation among healthcare workers in Ghana: parallel mediation effect of perceived HIV risk and perceived availability of PEP. [PDF]

BMJ Public Health
Salu PK, Sarfo JO, Amoadu M, Hormenu T.
europepmc   +1 more source

Beyond insulin-like growth factor-1 (IGF-1) normalization: portal insulin and hepatic growth hormone (GH) sensitivity across metabolic disease. [PDF]

Arch Endocrinol Metab
van AJ, Neggers SJ, Kopchick JJ, Boguszewski CL.   +3 more
europepmc   +1 more source

Asia-Pacific analysis of ESMO study on availability, out-of-pocket costs (OPC) and accessibility of antineoplastic medicines. [PDF]

ESMO Open
Wong ANM, Franco P, Sheikh HS, Pitiyarachchi O, Prasongsook N, Ordinario MV, Velasco R, Agarwala V, Dinh Tl A, Kapoor A, Kogawa T, Loong HH, Lui R, Luna HG, Matias M, Ng KYY, Selvaraj V, Sunggoro A, Thamlikitkul L, Cherny N.   +19 more
europepmc   +1 more source

A Generalizable Multimodal Model for Treatment-Stratified Risk and Survival Assessment under Real-World Constraints: A Multi-Center Study of Colorectal Cancer. [PDF]

Adv Sci (Weinh)
Cao C, Ji Z, He C, Wang J, Luo X, Liu J, Jing X, Yan F, Chen Y, Qu L, Yang S, Le Lu, Jiang Y, Wang X, Dou C, Zhao J.   +15 more
europepmc   +1 more source